• About
  • Investments
  • Press
  • Blog
  • Contact
Mark E. Watson III
  • About
  • Investments
  • Press
  • Blog
  • Contact
Select Page
The State of SPACs in InsurTech

The State of SPACs in InsurTech

by Mark E. Watson III | Dec 7, 2021 | Press

Formula for Success with Mark Watson

Formula for Success with Mark Watson

by Mark E. Watson III | Dec 7, 2021 | Press

Voice AI Technology to Increase as Hotel Operators Prepare for Upsurge in Guest Requests, According to NLX

Voice AI Technology to Increase as Hotel Operators Prepare for Upsurge in Guest Requests, According to NLX

by Mark E. Watson III | Dec 6, 2021 | Press

National Security Capital Advisors (NSCA) advises Freedom Consulting Group on its Recapitalization to Fund Growth

National Security Capital Advisors (NSCA) advises Freedom Consulting Group on its Recapitalization to Fund Growth

by Mark E. Watson III | Dec 3, 2021 | Press

Galderma buys U.S. skincare firm Alastin ahead of potential Zurich IPO

Galderma buys U.S. skincare firm Alastin ahead of potential Zurich IPO

by Mark E. Watson III | Nov 30, 2021 | Press

Galderma buys U.S. skincare firm Alastin ahead of potential Zurich IPO

Galderma to Acquire Award-winning ALASTIN Skincare®

by Mark E. Watson III | Nov 29, 2021 | Press

« Older Entries
Next Entries »

Recent Posts

  • Looking to start a business right now? Here’s what you need to know.
  • What every founder should know about innovation
  • Top 5 risk management mistakes that founders and business owners make
  • 6 (more) mistakes founders make when bringing in investors
  • Mark E. Watson III with Adam Mendler – Don’t Be the Hamster on the Wheel
  • Follow
  • Follow
  • Follow
© Copyright 2025. All Rights Reserved.

info@aquilavc.com